ROS-mediated decline in maximum Ca2+-activated force in rat skeletal muscle fibers following in vitro and in vivo stimulation.

ROS-mediated decline in maximum Ca2+-activated force in rat skeletal muscle fibers following in vitro and in vivo stimulation.

Item
http://www.wikidata.org/entity/Q34281511
Oxygen generating biomaterials preserve skeletal muscle homeostasis under hypoxic and ischemic conditionsNitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness.Weak by the machines: muscle motor protein dysfunction - a side effect of intensive care unit treatment.Repeated high-intensity exercise modulates Ca(2+) sensitivity of human skeletal muscle fibers.Mitochondria dysfunction in lung cancer-induced muscle wasting in C2C12 myotubes.Accessibility of myofilament cysteines and effects on ATPase depend on the activation state during exposure to oxidants.Protein thiol oxidation does not change in skeletal muscles of aging female mice.Changes in contractile and metabolic parameters of skeletal muscle as rats age from 3 to 12 months.Predominant cause of prolonged low-frequency force depression changes during recovery after in situ fatiguing stimulation of rat fast-twitch muscle.Contribution of impaired myofibril and ryanodine receptor function to prolonged low-frequency force depression after in situ stimulation in rat skeletal muscle.Thermal pretreatment facilitates recovery from prolonged low-frequency force depression in rat fast-twitch muscle
P2860

ROS-mediated decline in maximum Ca2+-activated force in rat skeletal muscle fibers following in vitro and in vivo stimulation.

Item
http://www.wikidata.org/entity/Q34281511
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@ast
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@en
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@nl
type
label
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@ast
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@en
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@nl
prefLabel
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@ast
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@en
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
ROS-mediated decline in maximu ...... vitro and in vivo stimulation.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0035226
P407
P433
P478
P50
P577
P5875
P698
P932